RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Gongwin Biopharm Holdings Co - Stock

Gongwin Biopharm Holdings Co ROCE 2024

Gongwin Biopharm Holdings Co ROCE

-0.1

Ticker

6617.TWO

ISIN

KYG409471060

In 2024, Gongwin Biopharm Holdings Co's return on capital employed (ROCE) was -0.1, a -45.89% increase from the -0.19 ROCE in the previous year.

Gongwin Biopharm Holdings Co Aktienanalyse

What does Gongwin Biopharm Holdings Co do?

Gongwin Biopharm Holdings Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Gongwin Biopharm Holdings Co's Return on Capital Employed (ROCE)

Gongwin Biopharm Holdings Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Gongwin Biopharm Holdings Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Gongwin Biopharm Holdings Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Gongwin Biopharm Holdings Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Gongwin Biopharm Holdings Co Stock

What is the ROCE (Return on Capital Employed) of Gongwin Biopharm Holdings Co this year?

The ROCE of Gongwin Biopharm Holdings Co is -0.1 undefined this year.

How has the ROCE (Return on Capital Employed) of Gongwin Biopharm Holdings Co developed compared to the previous year?

The ROCE of Gongwin Biopharm Holdings Co has increased by -45.89% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Gongwin Biopharm Holdings Co?

A high Return on Capital Employed (ROCE) indicates that Gongwin Biopharm Holdings Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Gongwin Biopharm Holdings Co?

A low ROCE (Return on Capital Employed) can indicate that Gongwin Biopharm Holdings Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Gongwin Biopharm Holdings Co impact the company?

An increase in the ROCE of Gongwin Biopharm Holdings Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Gongwin Biopharm Holdings Co affect the company?

A decrease in ROCE of Gongwin Biopharm Holdings Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Gongwin Biopharm Holdings Co?

Some factors that can affect Gongwin Biopharm Holdings Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Gongwin Biopharm Holdings Co so important for investors?

The ROCE of Gongwin Biopharm Holdings Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Gongwin Biopharm Holdings Co take to improve the ROCE?

To improve the ROCE, Gongwin Biopharm Holdings Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Gongwin Biopharm Holdings Co pay?

Over the past 12 months, Gongwin Biopharm Holdings Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gongwin Biopharm Holdings Co is expected to pay a dividend of 0 TWD.

What is the dividend yield of Gongwin Biopharm Holdings Co?

The current dividend yield of Gongwin Biopharm Holdings Co is .

When does Gongwin Biopharm Holdings Co pay dividends?

Gongwin Biopharm Holdings Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gongwin Biopharm Holdings Co?

Gongwin Biopharm Holdings Co paid dividends every year for the past 0 years.

What is the dividend of Gongwin Biopharm Holdings Co?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gongwin Biopharm Holdings Co located?

Gongwin Biopharm Holdings Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gongwin Biopharm Holdings Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gongwin Biopharm Holdings Co from 7/2/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.

When did Gongwin Biopharm Holdings Co pay the last dividend?

The last dividend was paid out on 7/2/2024.

What was the dividend of Gongwin Biopharm Holdings Co in the year 2023?

In the year 2023, Gongwin Biopharm Holdings Co distributed 0 TWD as dividends.

In which currency does Gongwin Biopharm Holdings Co pay out the dividend?

The dividends of Gongwin Biopharm Holdings Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gongwin Biopharm Holdings Co

Our stock analysis for Gongwin Biopharm Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gongwin Biopharm Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.